General Information of Drug (ID: DM3VNK0)

Drug Name
BDBM50080563 Drug Info
Synonyms CHEMBL3422425; SCHEMBL16055775; BDBM50080563
Cross-matching ID
PubChem CID
86299710
TTD Drug ID
DM3VNK0

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
US9522888, 575 DM6UXZK N. A. N. A. Patented [2]
US9617250, Example 1 Example 204 of D1 DM89LKQ N. A. N. A. Patented [1]
YYDJCLCSBYCSCO-UHFFFAOYSA-N DMA91FM N. A. N. A. Patented [3]
US9216972, 61 DM7AHQE N. A. N. A. Patented [4]
US9670220, 77 DMZG1HO N. A. N. A. Patented [5]
US10179791, Compound 296 DMLZBRM N. A. N. A. Patented [6]
JCXGHZCWAHCYGY-UHFFFAOYSA-N DMER7QX N. A. N. A. Patented [3]
US9216972, 67 DMXR5SZ N. A. N. A. Patented [4]
US10166249, Example 695 DMVMNP1 N. A. N. A. Patented [7]
US9181182, 40 DM3QIF4 N. A. N. A. Patented [8]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Sphingosine-1-phosphate receptor 3 (S1PR3) TTDYP7I S1PR3_HUMAN Inhibitor [1]

References

1 Pyridin-4-yl derivatives. US9617250.
2 Substituted bicyclic compounds. US9522888.
3 6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (S1P) receptor for the treatment of multiple sclerosis. US9150519.
4 Tricyclic heterocyclic compounds. US9216972.
5 Fused heterocyclic derivatives as S1P modulators. US9670220.
6 Spiro-cyclic amine derivatives as S1P modulators. US10179791.
7 Substituted bicyclic compounds. US10166249.
8 S1P receptors modulators. US9181182.